Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01024894
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy

Who this might be right for
Hepatitis C
Cytheris SA 15
Testing effectiveness (Phase 2)Study completedNCT00606086
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Who this might be right for
Genotype 1 Chronic Hepatitis C
GlobeImmune 140
Testing effectiveness (Phase 2)Study completedNCT01994486
What this trial is testing

Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
University of Florida 20
Early research (Phase 1)Study completedNCT00823862
What this trial is testing

Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C
Dynavax Technologies Corporation 34
Testing effectiveness (Phase 2)Study completedNCT02405013
What this trial is testing

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

Who this might be right for
Hepatitis CHIV Infection
ANRS, Emerging Infectious Diseases 120
Large-scale testing (Phase 3)Study completedNCT02252016
What this trial is testing

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 159
Large-scale testing (Phase 3)Study completedNCT01292239
What this trial is testing

A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 183
Testing effectiveness (Phase 2)WithdrawnNCT01157975
What this trial is testing

Study the Relationship Between Obesity and Hepatitis C Replication

Who this might be right for
Hepatitis C
University of California, San Diego
Testing effectiveness (Phase 2)Study completedNCT00528528
What this trial is testing

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Who this might be right for
Chronic Hepatitis C
Tibotec BVBA 166
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT02074514
What this trial is testing

Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 117
Large-scale testing (Phase 3)Study completedNCT01281839
What this trial is testing

An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy

Who this might be right for
Hepatitis C
Janssen R&D Ireland 394
Testing effectiveness (Phase 2)Study completedNCT01359644
What this trial is testing

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 350
Testing effectiveness (Phase 2)Study completedNCT01899092
What this trial is testing

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Large-scale testing (Phase 3)Study completedNCT01006031
What this trial is testing

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Who this might be right for
Liver CirrhosisHepatitis C VirusHIV Infection
Sociedad Andaluza de Enfermedades Infecciosas 25
Early research (Phase 1)Ended earlyNCT01554085
What this trial is testing

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 78
Testing effectiveness (Phase 2)Study completedNCT01587586
What this trial is testing

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
PharmaEssentia 107
Not applicableUnknownNCT03407703
What this trial is testing

Hepatitis C (HCV) Cure and Kidney Health

Who this might be right for
Hepatitis C
San Francisco Veterans Affairs Medical Center 50
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Early research (Phase 1)Ended earlyNCT01586325
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients

Who this might be right for
Chronic Hepatitis C Infection
Janssen R&D Ireland 8
Next Page